Kenneth Joseph Keller
Director/Board Member at AMBIT BIOSCIENCES CORP
Profile
Kenneth Joseph Keller is currently the President & Chief Executive Officer at Daiichi Sankyo, Inc. and the Director at Ambit Biosciences Corp.
Previously, he served as the President & Chief Executive Officer at American Regent, Inc. and as the Chief Operating Officer & Executive Vice President at Spectrum Pharmaceuticals, Inc. Mr. Keller holds an MBA from Loyola Marymount University and an undergraduate degree from St. John's University.
Kenneth Joseph Keller active positions
Companies | Position | Start |
---|---|---|
AMBIT BIOSCIENCES CORP | Director/Board Member | 10/11/2014 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Chief Executive Officer | - |
Former positions of Kenneth Joseph Keller
Companies | Position | End |
---|---|---|
American Regent, Inc.
American Regent, Inc. Pharmaceuticals: MajorHealth Technology American Regent, Inc. manufactures and distributes pharmaceutical products. It offers generic and branded injectables as well as intravenous iron therapies. The company was founded in 1967 and is headquartered in Shirley, NY. | Chief Executive Officer | 01/04/2021 |
SPECTRUM PHARMACEUTICALS, INC. | Chief Operating Officer | 17/04/2014 |
Training of Kenneth Joseph Keller
St. John's University | Undergraduate Degree |
Loyola Marymount University | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
Private companies | 3 |
---|---|
Ambit Biosciences Corp.
Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA. | Health Technology |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
American Regent, Inc.
American Regent, Inc. Pharmaceuticals: MajorHealth Technology American Regent, Inc. manufactures and distributes pharmaceutical products. It offers generic and branded injectables as well as intravenous iron therapies. The company was founded in 1967 and is headquartered in Shirley, NY. | Health Technology |
- Stock Market
- Insiders
- Kenneth Joseph Keller